ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Neopharm

Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingIL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
2.RecruitingInterstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Conditions: Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Mixed Oligoastrocytoma
3.RecruitingLiposome Encapsulated SN38 (LE-SN38) in Patients with Advanced Cancer
Condition: Neoplasms
4.RecruitingLiposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients with Advanced Cancer
Condition: Neoplasm
5.RecruitingThe PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients with Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act